序号 |
标题 |
次数 |
作者 |
发布时间 |
55351 |
DSPE-PEG2000-CH2COOH,2665069-75-8,二硬脂酰基磷脂酰乙醇胺-聚乙二醇-二氯甲烷羧基,DSPE-PEG-CH2COOH |
77 |
axc |
2025-02-10 |
55352 |
Peptides PEG DSPE 多肽-聚乙二醇-二硬脂酰基磷脂酰乙醇胺 |
98 |
kx |
2025-02-10 |
55353 |
DSPE-PEG2000-Boronate,二硬脂酰基磷脂酰乙醇胺-聚乙二醇-硼酸酯,DSPE-PEG-Boronate |
154 |
axc |
2025-02-10 |
55354 |
Xpeptide-PEG-PCL Xpeptide多肽-聚乙二醇-聚已内酯 |
80 |
kx |
2025-02-10 |
55355 |
DSPE-PEG2000-Biotin,740794-01-8,二硬脂酰基磷脂酰乙醇胺-聚乙二醇-生物素,DSPE-PEG-Biotin |
98 |
axc |
2025-02-10 |
55356 |
DSPE-PEG5-azide,2112737-73-0,二硬脂酰基磷脂酰乙醇胺-五聚乙二醇-叠氮,DSPE-PEG-azide |
69 |
axc |
2025-02-10 |
55357 |
FITC/CY3/CY5/CY7荧光标记方法步骤 |
125 |
WYQ |
2025-02-10 |
55358 |
M2pep-PEG-PCL M2型巨噬细胞靶向肽-聚乙二醇-聚已内酯 |
67 |
kx |
2025-02-10 |
55359 |
Br-PEG1000-Br 溴-聚乙二醇-溴 |
106 |
zyl |
2025-02-10 |
55360 |
选择合适的荧光染料和特异性荧光显微镜 |
124 |
WYQ |
2025-02-10 |
55361 |
DSPE-PEG2000-azide,1938081-39-0,二硬脂酰基磷脂酰乙醇胺-聚乙二醇-叠氮,DSPE-PEG-azide |
76 |
axc |
2025-02-10 |
55362 |
荧光FITC标记多糖的方法步骤 |
152 |
WYQ |
2025-02-10 |
55363 |
DSPE-PEG2000-Amine,474922-26-4,二硬脂酰基磷脂酰乙醇胺-聚乙二醇-氨基,DSPE-PEG-Amine |
72 |
axc |
2025-02-10 |
55364 |
T7-PEG-PCL 脑靶向肽T7-聚乙二醇-聚已内酯 |
108 |
kx |
2025-02-10 |
55365 |
DSPE-PEG2000-Ald,二硬脂酰基磷脂酰乙醇胺-聚乙二醇-醛基,DSPE-PEG-Ald |
133 |
axc |
2025-02-10 |
55366 |
COCl-PEG1000-COCl 琥珀酰氯-聚乙二醇-琥珀酰氯 |
122 |
zyl |
2025-02-10 |
55367 |
DSPE-PEG2000-acid,2112738-58-4,二硬脂酰基磷脂酰乙醇胺-四聚乙二醇-羧酸,DSPE-PEG4-acid |
61 |
axc |
2025-02-10 |
55368 |
提取和纯化灰树花多糖的方法 |
95 |
WYQ |
2025-02-10 |
55369 |
DSPE-PEG2000-acid,二硬脂酰基磷脂酰乙醇胺-聚乙二醇-羧酸,DSPE-PEG-acid |
57 |
axc |
2025-02-10 |
55370 |
Cl-PEG1000-Cl 氯化物-聚乙二醇-氯化物 |
92 |
zyl |
2025-02-10 |
55371 |
Peptides PEG PCL 多肽-聚乙二醇-聚已内酯 |
86 |
kx |
2025-02-10 |
55372 |
Peptides-PEG-PCL 多肽-聚乙二醇-聚已内酯 |
69 |
kx |
2025-02-10 |
55373 |
IA-PEG1000-SC 碘代乙酰基-聚乙二醇-琥珀酰亚胺碳酸酯 |
74 |
zyl |
2025-02-10 |
55374 |
IA-PEG1000-Mal 碘代乙酰基-聚乙二醇-马来酰亚胺 |
91 |
zyl |
2025-02-10 |
55375 |
FITC标记PGF灰树花多糖时调节温度的原因 |
69 |
WYQ |
2025-02-10 |
55376 |
Peptides PEG PLA 多肽-聚乙二醇-聚乳酸 |
69 |
kx |
2025-02-10 |
55377 |
IA-PEG1000-Biotin 碘代乙酰基-聚乙二醇-生物素 |
75 |
zyl |
2025-02-10 |
55378 |
PTP-PEG-N3 胰腺癌靶向肽PTP-聚乙二醇-叠氮 |
76 |
kx |
2025-02-10 |
55379 |
PTP-PEG-COOH 胰腺癌靶向肽PTP-聚乙二醇-羧酸 |
64 |
kx |
2025-02-10 |
55380 |
PTP PEG 胰腺癌靶向肽PTP-聚乙二醇 |
64 |
kx |
2025-02-10 |
55381 |
FITC标记PGF灰树花多糖时调节pH值的原因 |
65 |
WYQ |
2025-02-10 |
55382 |
Angiopep-2-PEG-N3 脑部靶向分子-聚乙二醇-叠氮 |
61 |
kx |
2025-02-10 |
55383 |
Angiopep-2-PEG-COOH 脑部靶向分子-聚乙二醇-羧酸 |
74 |
kx |
2025-02-10 |
55384 |
Angiopep-2 PEG 脑部靶向分子-聚乙二醇 |
141 |
kx |
2025-02-10 |
55385 |
iRGD-PEG-MAL 环肽iRGD-聚乙二醇-马来酰亚胺 |
76 |
kx |
2025-02-10 |
55386 |
iRGD-PEG-N3 环肽iRGD-聚乙二醇-叠氮 |
80 |
kx |
2025-02-10 |
55387 |
iRGD-PEG-SH 环肽iRGD-聚乙二醇-硫基 |
63 |
kx |
2025-02-10 |
55388 |
FITC-PGF荧光标记反应结束后纯化标记的灰树花多糖 |
119 |
WYQ |
2025-02-10 |
55389 |
cRGD-PEG-PEI cRGD靶向环肽-聚乙二醇-聚乙烯亚胺 |
78 |
kx |
2025-02-10 |
55390 |
1622335-40-3,ICG-NHS吲哚菁绿-活性酯 |
67 |
WYQ |
2025-02-10 |
55391 |
IA-PEG1000-COOH 碘代乙酰基-聚乙二醇-羧基 |
107 |
zyl |
2025-02-10 |
55392 |
ICG-NHS吲哚菁绿活化酯试剂的保存与检测 |
92 |
WYQ |
2025-02-10 |
55393 |
Br-PEG1000-Mal 溴-聚乙二醇-马来酰亚胺 |
63 |
zyl |
2025-02-10 |
55394 |
cRGD-PEG-N3 cRGD靶向环肽-聚乙二醇-叠氮 |
61 |
kx |
2025-02-10 |
55395 |
ICG-NHS标记后的生物分子光谱分析验证方法 |
99 |
WYQ |
2025-02-10 |